Table 3.
Variables | AHI <15, n = 50 | AHI15-30, n = 37 | AHI >30, n = 54 | p value |
---|---|---|---|---|
Clinical characteristics | ||||
Gender, n (%) | ||||
Male | 5 (10.00) | 6 (16.22) | 19 (35.19) | 0.005* |
Female | 45 (90.00) | 31 (83.78) | 35 (64.81) | |
Age, years | 29.88±6.17 | 30.46±7.68 | 31.91±6.77 | 0.301 |
BMI, kg/m2 | 36.33±6.46 | 40.37±7.76 | 42.53±7.76 | 0.000* |
Waist circumference, cm | 107.00 (101.00–115.75) | 120.00 (111.50–129.50) | 123.50 (110.75–135.25) | 0.000* |
Neck circumference, cm | 40.00 (37.75–43.00) | 41.50 (40.00–43.00) | 44.00 (41.00–47.00) | 0.000* |
Smoking, n (%) | 4 (8.00) | 3 (8.11) | 10 (18.52) | 0.329 |
Comorbidity, n (%) | ||||
Diabetes | 17 (34.00) | 10 (27.03) | 22 (40.74) | 0.398 |
Arterial hypertension | 14 (28.00) | 9 (24.32) | 21 (38.89) | 0.281 |
Dyslipidemia | 44 (88.00) | 33 (89.19) | 47 (87.04) | 0.953 |
Biochemical characteristics | ||||
ALT, U/L | 38.50 (26.75–66.50) | 44.00 (29.00–90.00) | 52.00 (27.75–75.00) | 0.432 |
AST, U/L | 23.00 (17.00–35.25) | 27.00 (17.00–48.50) | 27.50 (18.75–51.00) | 0.370 |
ALKP, U/L | 70.00 (57.00–80.25) | 69.00 (62.50–82.50) | 69.00 (61.00–83.00) | 0.853 |
GGT, U/L | 31.00 (22.25–54.00) | 41.00 (27.00–50.00) | 44.00 (24.50–66.50) | 0.362 |
TC, mmol/L | 4.89 (4.42–5.50) | 4.96 (4.51–5.33) | 5.04 (4.47–5.58) | 0.968 |
TG, mmol/L | 1.66 (1.42–2.30) | 2.05 (1.55–2.91) | 1.81 (1.43–2.47) | 0.203 |
HDL-C, mmol/L | 1.09 (0.99–1.26) | 1.04 (0.91–1.14) | 1.04 (0.92–1.17) | 0.029* |
LDL-C, mmol/L | 3.15±0.63 | 3.34±0.75 | 3.30±0.82 | 0.441 |
Fasting glucose, mmol/L | 5.36 (4.89–6.77) | 5.36 (4.90–6.62) | 5.79 (5.08–6.75) | 0.516 |
Fasting insulin, µIU/mL | 18.50 (14.03–24.48) | 27.10 (17.85–33.80) | 25.10 (17.90–33.63) | 0.006* |
HOMA-IR | 4.85 (3.10–6.96) | 6.39 (4.76–8.34) | 6.31 (4.69–9.00) | 0.021* |
AHI, apnea-hypopnea index; BMI, body mass index; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALKP, alkaline phosphatase; GGT, gamma glutamyl transferase; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance.
*p < 0.05.